Abstract：
:In this issue of Cancer Cell, Park et al. demonstrate that anti-erbB2 antibody primes adaptive immunity for increased tumor clearance and suggest that chemotherapy may in fact interfere with this process.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Smyth MJ,Stagg Jdoi
10.1016/j.ccr.2010.07.009subject
Has Abstractpub_date
2010-08-09 00:00:00pages
101-2issue
2eissn
1535-6108issn
1878-3686pii
S1535-6108(10)00279-5journal_volume
18pub_type
评论,杂志文章相关文献
CANCER CELL文献大全abstract：:Atypical protein kinase C (aPKC) isozymes, PKCλ/ι and PKCζ, are now considered fundamental regulators of tumorigenesis. However, the specific separation of functions that determine their different roles in cancer is still being unraveled. Both aPKCs have pleiotropic context-dependent functions that can translate into ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2019.07.010
更新日期：2019-09-16 00:00:00
abstract：:Tumors are influenced by the mechanical properties of their microenvironment. Using patient samples and atomic force microscopy, we found that tissue stiffness is higher in liver metastases than in primary colorectal tumors. Highly activated metastasis-associated fibroblasts increase tissue stiffness, which enhances a...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.05.005
更新日期：2020-06-08 00:00:00
abstract：:In this issue of Cancer Cell, Gruber et al. report that a significant proportion of children with acute megakaryoblastic leukemia acquire a translocation that confers enhanced BMP signaling and promotes self-renewal of hematopoietic progenitors. This study presents novel therapeutic targets that may lead to improved t...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2012.10.008
更新日期：2012-11-13 00:00:00
abstract：:Targeted protein degradation is an emerging technology for drug development. An article published in Nature reported a novel mechanism of targeted protein degradation triggered by small-molecule-induced polymerization of the oncogenic transcription factor BCL6. ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.12.020
更新日期：2021-01-11 00:00:00
abstract：:Rhabdomyosarcoma is a soft-tissue sarcoma with molecular and cellular features of developing skeletal muscle. Rhabdomyosarcoma has two major histologic subtypes, embryonal and alveolar, each with distinct clinical, molecular, and genetic features. Genomic analysis shows that embryonal tumors have more structural and c...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.11.002
更新日期：2013-12-09 00:00:00
abstract：:Glioma-initiating cells (GICs) are responsible for the initiation and recurrence of gliomas. Here, we identify a molecular mechanism that regulates the self-renewal capacity of patient-derived GICs. We show that TGF-beta and LIF induce the self-renewal capacity and prevent the differentiation of GICs. TGF-beta induces...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2009.02.011
更新日期：2009-04-07 00:00:00
abstract：:We investigated the transcriptional and epigenetic repression of miR-29 by MYC, HDAC3, and EZH2 in mantle cell lymphoma and other MYC-associated lymphomas. We demonstrate that miR-29 is repressed by MYC through a corepressor complex with HDAC3 and EZH2. MYC contributes to EZH2 upregulation via repression of the EZH2 t...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2012.09.003
更新日期：2012-10-16 00:00:00
abstract：:The E2F family of transcription factors is critical for the control of cell cycle progression. We now show that the specific inactivation of E2F3 in mouse embryo fibroblasts (MEFs) results in a disruption of the centrosome duplication cycle. Loss of E2F3, but not E2F1, E2F2, E2F4, or E2F5 results in unregulated cyclin...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(03)00083-7
更新日期：2003-04-01 00:00:00
abstract：:Cancer-associated chromosomal translocations create chimeric oncoproteins that contribute to aberrant growth by dominant or dominant negative mechanisms. Interestingly, genes such as MLL, RARA, and EWS are fused to multiple partners. This molecular promiscuity can provide important functional information, as specific ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(04)00060-1
更新日期：2004-03-01 00:00:00
abstract：:Immune checkpoint-blockade treatments targeting PD-1/PD-L1 have revolutionized cancer therapy. Hence, understanding the regulation of PD-L1 expression has major clinical relevance. In this issue of Cancer Cell, Lim et al. report that inflammation-induced and NF-κB-driven expression of deubiquitinating enzyme CSN5 lead...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.11.013
更新日期：2016-12-12 00:00:00
abstract：:Agonistic antibodies specific for members of the tumor necrosis factor receptor protein family hold great promise for immunotherapy of cancer. In this issue of Cancer Cell, White and colleagues provide evidence that the human IgG2 subclass may represent a superior backbone for the use of these antibodies in human ther...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2014.12.010
更新日期：2015-01-12 00:00:00
abstract：:The Twist1 transcription factor is known to promote tumor metastasis and induce Epithelial-Mesenchymal Transition (EMT). Here, we report that Twist1 is capable of promoting the formation of invadopodia, specialized membrane protrusions for extracellular matrix degradation. Twist1 induces PDGFRα expression, which in tu...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.01.036
更新日期：2011-03-08 00:00:00
abstract：:Ras proteins play a major role in human cancers but have not yielded to therapeutic attack. Ras-driven cancers are among the most difficult to treat and often excluded from therapies. The Ras proteins have been termed "undruggable," based on failures from an era in which understanding of signaling transduction, feedba...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccr.2014.02.017
更新日期：2014-03-17 00:00:00
abstract：:The proapoptotic death receptor DR5 has been studied extensively in cancer cells, but its action in the tumor microenvironment is not well defined. Here, we uncover a role for DR5 signaling in tumor endothelial cells (ECs). We detected DR5 expression in ECs within tumors but not normal tissues. Treatment of tumor-bear...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2012.05.014
更新日期：2012-07-10 00:00:00
abstract：:Malignant melanoma is characterized by frequent metastasis, however, specific changes that regulate this process have not been clearly delineated. Although it is well known that Wnt signaling is frequently dysregulated in melanoma, the functional implications of this observation are unclear. By modulating β-catenin le...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.10.030
更新日期：2011-12-13 00:00:00
abstract：:How loss-of-function of GATA3 contributes to the development of breast cancer is poorly understood. Here, we report that GATA3 nucleates a transcription repression program composed of G9A and MTA3-, but not MTA1- or MTA2-, constituted NuRD complex. Genome-wide analysis of the GATA3/G9A/NuRD(MTA3) targets identified a ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2015.04.011
更新日期：2015-06-08 00:00:00
abstract：:The COVID-19 pandemic is profoundly changing cancer researchers and cancer research. Leaders from different fields and at different career stages share their perspectives. ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.10.007
更新日期：2020-11-09 00:00:00
abstract：:EGFRvIII, a frequently occurring mutation in primary glioblastoma, results in a protein product that cannot bind ligand, but signals constitutively. Deducing how EGFRvIII causes transformation has been difficult because of autocrine and paracrine loops triggered by EGFRvIII alone or in heterodimers with wild-type EGFR...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.09.004
更新日期：2013-10-14 00:00:00
abstract：:MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single nucleotide polymorphism (SNP) in the human MDM2 promoter increases the affinity of Sp1 resulting in elevated MDM2 levels. We generated mice carrying either the MDM2(SNP309T) or the MDM2(SNP309G) allele to address the imp...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2010.07.010
更新日期：2010-09-14 00:00:00
abstract：:Deregulation of growth factor receptor tyrosine kinases (RTKs) is linked to a large number of malignancies. This occurs through a variety of mechanisms that result in enhanced activity of the receptor. Considerable evidence now supports the idea that loss of negative regulation plays an important role in receptor dere...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(03)00136-3
更新日期：2003-06-01 00:00:00
abstract：:Solid tumors require new blood vessels for growth and metastasis, yet the biology of tumor-specific endothelial cells is poorly understood. We have isolated tumor endothelial cells from mice that spontaneously develop prostate tumors. Clonal populations of tumor endothelial cells expressed hematopoietic and mesenchyma...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2008.06.017
更新日期：2008-09-09 00:00:00
abstract：:Mechanisms for breast cancer recurrence and metastases are poorly understood. New evidence from a transgenic mouse mammary tumor model suggests that the transcriptional repressor, Snail, may play a role in recurrence by downregulating E-cadherin and inducing an epithelial-to-mesenchymal transition. Preliminary informa...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2005.08.006
更新日期：2005-09-01 00:00:00
abstract：:HIF-2alpha promotes von Hippel-Lindau (VHL)-deficient renal clear cell carcinoma (RCC) tumorigenesis, while HIF-1alpha inhibits RCC growth. As HIF-1alpha antagonizes c-Myc function, we hypothesized that HIF-2alpha might enhance c-Myc activity. We demonstrate here that HIF-2alpha promotes cell-cycle progression in hypo...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2007.02.006
更新日期：2007-04-01 00:00:00
abstract：:Recent evidence suggests that human cells require more genetic changes for neoplastic transformation than do their murine counterparts. However, a precise enumeration of these differences has never been undertaken. We have determined that perturbation of two signaling pathways-involving p53 and Raf-suffices for the tu...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2004.07.009
更新日期：2004-08-01 00:00:00
abstract：:During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, an...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(03)00216-2
更新日期：2003-09-01 00:00:00
abstract：:In this issue of Cancer Cell, Kudo et al. identify a novel tumor suppressor role for PKCλ/ι in hepatocellular carcinoma. Loss of PKCλ/ι in obesity-driven liver cancer results in cellular metabolic reprogramming that induces two reciprocally sustainable processes, oxidative phosphorylation and autophagy, which promote ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.07.003
更新日期：2020-08-10 00:00:00
abstract：:There are 17 known ubiquitin-like proteins (UBLs) from nine phylogenetically distinct classes (NEDD8, SUMO, ISG15, FUB1, FAT10, Atg8, Atg12, Urm1, and UFM1) that have been identified to conjugate to substrates in a manner analogous to ubiquitin. NEDD8 is one of the most studied UBLs and shares the highest amino acid s...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccr.2011.01.002
更新日期：2011-02-15 00:00:00
abstract：:Genome-wide cancer mutation analyses are revealing an extensive landscape of functional mutations within the noncoding genome, with profound effects on the expression of long noncoding RNAs (lncRNAs). While the exquisite regulation of lncRNA transcription can provide signals of malignant transformation, we now underst...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2016.03.010
更新日期：2016-04-11 00:00:00
abstract：:Undifferentiated sarcomas (USARCs) of adults are diverse, rare, and aggressive soft tissue cancers. Recent sequencing efforts have confirmed that USARCs exhibit one of the highest burdens of structural aberrations across human cancer. Here, we sought to unravel the molecular basis of the structural complexity in USARC...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2019.02.002
更新日期：2019-03-18 00:00:00
abstract：:TERT promoter mutations reactivate telomerase, allowing for indefinite telomere maintenance and enabling cellular immortalization. These mutations specifically recruit the multimeric ETS factor GABP, which can form two functionally independent transcription factor species: a dimer or a tetramer. We show that genetic d...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2018.08.003
更新日期：2018-09-10 00:00:00
